Heart Failure with Preserved Ejection Fraction (HFpEF) Latest Advances

Reversible Fibroblast Trajectories Regulated by MR Underlie Diastolic Dysfunction.

Journal: Circulation research

Published: April 15, 2026

Assessment of Coronary Flow Reserve in a Mouse Model of Heart Failure with Preserved Ejection Fraction Using Doppler Echocardiography.

Journal: Journal of visualized experiments : JoVE

Published: April 13, 2026

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan　- Insights From the PARACLETE Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: April 12, 2026

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Journal: Annals of medicine

Published: April 10, 2026

PCPE-1 promotes cardiac fibrosis with aging and obesity.

Journal: JCI insight

Published: April 09, 2026

Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.

Journal: Journal of cardiovascular pharmacology

Published: April 08, 2026

Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction.

Journal: Circulation

Published: April 07, 2026

Prevalence and Factors Associated With Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Meta-Regression.

Journal: Cardiology in review

Published: April 07, 2026

Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.

Journal: Circulation

Published: April 02, 2026

Transcatheter aortic valve replacement at metropolitan teaching hospitals among patients with heart failure.

Journal: Current problems in cardiology

Published: April 02, 2026

LIFE-Preserved enables long-term risk prediction in patients with heart failure with preserved ejection fraction.

Journal: Nature cardiovascular research

Published: April 01, 2026

Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: March 31, 2026

Heart Failure with Preserved Ejection Fraction (HFpEF) Latest Advances

Find the Latest Research About Heart Failure with Preserved Ejection Fraction (HFpEF)

Reversible Fibroblast Trajectories Regulated by MR Underlie Diastolic Dysfunction.

Reversible Fibroblast Trajectories Regulated by MR Underlie Diastolic Dysfunction.

Assessment of Coronary Flow Reserve in a Mouse Model of Heart Failure with Preserved Ejection Fraction Using Doppler Echocardiography.

Assessment of Coronary Flow Reserve in a Mouse Model of Heart Failure with Preserved Ejection Fraction Using Doppler Echocardiography.

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan - Insights From the PARACLETE Study.

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan - Insights From the PARACLETE Study.

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

PCPE-1 promotes cardiac fibrosis with aging and obesity.

PCPE-1 promotes cardiac fibrosis with aging and obesity.

Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.

Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.

Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction.

Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction.

Prevalence and Factors Associated With Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Meta-Regression.

Prevalence and Factors Associated With Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Meta-Regression.

Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.

Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.

Transcatheter aortic valve replacement at metropolitan teaching hospitals among patients with heart failure.

Transcatheter aortic valve replacement at metropolitan teaching hospitals among patients with heart failure.

LIFE-Preserved enables long-term risk prediction in patients with heart failure with preserved ejection fraction.

LIFE-Preserved enables long-term risk prediction in patients with heart failure with preserved ejection fraction.

Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam.

Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam.

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan　- Insights From the PARACLETE Study.

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan　- Insights From the PARACLETE Study.